XLVIvsJDOCETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.49%
VS
State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. Both ETFs have the same top 2 sector exposures: Healthcare and Consumer Non-Cyclicals. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.65% for JDOC. XLVI is up 5.69% year-to-date (YTD) with +$14M in YTD flows. JDOC performs worse with 4.98% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of XLVI and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI vs JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI JDOC | -3.75%-2.89% | +3.97%+6.88% | +5.69%+4.98% | +16.54%+18.58% | n/an/a | n/an/a |
| Flows | XLVI JDOC | +$4M- | +$11M- | +$14M-$34K | +$25M-$34K | -- | -- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI JDOC | +11.87%+17.67% | +11.09%+15.47% | n/an/a | n/an/a |
| Max drawdown | XLVI JDOC | -4.77%-5.88% | -8.21%-9.66% | n/an/a | n/an/a |
| Max drawdown duration | XLVI JDOC | 16d16d | 115d154d | n/an/a | n/an/a |
Trading data
XLVI | JDOC | |
Last sale 9/11/2026 at 1:30 PM | $25.71 | $60.72 |
| Previous close 09/10/2026 | $25.73 | $60.81 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI | JDOC | |
|---|---|---|
| Last price | $25.71 | $60.72 |
| 1D performance | -0.07% | -0.15% |
| AuM | $25.47 M | $9.11 M |
| E/R | 0.35% | 0.65% |
Characteristics
XLVI | JDOC | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | State Street Investment Management | J.P. Morgan Asset Management |
| Benchmark | - | - |
| N° of holdings | 59 | 57 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | November 1, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLVI
USA
97.34%
Other
2.66%
JDOC
USA
76.59%
Other
23.41%
Sectors
XLVI
Healthcare
97.32%
Other
2.68%
JDOC
Healthcare
96.82%
Other
3.18%
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
71.63%
JDOC
Total weight of top 15 holdings out of 15
61.77%
Top 15 holdings
Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
JDOC
Eli Lilly & Co.
8.05%
AbbVie, Inc.
7.99%
UnitedHealth Group, Inc.
6.22%
Johnson & Johnson
4.97%
Merck & Co., Inc.
4.81%
AstraZeneca PLC
3.75%
Thermo Fisher Scientific, Inc.
3.62%
Bristol Myers Squibb Co.
3.40%
CVS Health Corp.
3.18%
Abbott Laboratories
3.06%
Roche Holding AG
2.82%
Novo Nordisk A/S
2.72%
argenx SE
2.45%
GSK Plc
2.44%
Stryker Corp.
2.29%
Frequently asked questions about XLVI and JDOC
How have the XLVI and JDOC ETFs performed in 2026?
As of September 10, 2026, XLVI is up 5.69% year-to-date (YTD), while JDOC has returned 4.98%. That puts XLVI better performer ahead so far this year.
Which ETF is attracting more investor money: XLVI or JDOC?
Year-to-date, the XLVI ETF saw +$14M in flows, compared to -$34K for JDOC.
Which ETF is more volatile: XLVI or JDOC?
Over the past year, XLVI had a volatility of 11.09%, while JDOC experienced 15.47%.
Which ETF is bigger: XLVI or JDOC?
As of September 10, 2026, XLVI holds $25.47 M in assets under management (AUM), while JDOC manages $9.11 M.
What sectors do the XLVI and JDOC ETFs invest in?
XLVI leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.
What are the top holdings of the XLVI ETF and JDOC ETF?
XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..
Which ETF is more diversified: XLVI or JDOC?
XLVI holds 59 securities with 71.63% of its assets in the top 15. JDOC has 57 securities and a top 15 weight of 61.77%.
Advertisement
Advertisement
